A machine learning-assisted hypoxia-associated prognostic model reveals PFKP-mediated glycolytic regulation in uveal melanoma
Source check: Source checked. Not independent scientific confirmation.
Finding: In a TCGA uveal-melanoma cohort (n=80), machine-learning approaches nominated prognostic candidates; ENO3/PFKP were evaluated in an independent cohort. PFKP perturbation experiments reported changes in proliferation, glycolysis and xenograft growth. Author affiliations were not available in the reviewed publisher passages; organization left empty.
Technology: Five machine-learning survival approaches; multivariable Cox modeling
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Five machine-learning survival approaches; multivariable Cox modeling
- Test and result
- In a TCGA uveal-melanoma cohort (n=80), machine-learning approaches nominated prognostic candidates; ENO3/PFKP were evaluated in an independent cohort. PFKP perturbation experiments reported changes in proliferation, glycolysis and xenograft growth.
- Limitation / still unknown
- The prognostic associations and experimental perturbations do not establish the full human disease mechanism.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1993731/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.